Pradaxa Could Cause Uncontrollable Bleeding, Experts Say

Share Article

The Pradaxa Resource Center is the Web’s largest source for information on Pradaxa research, side effects and legal news. Visit http://www.Pradaxa-lawsuits.org

Pradaxa lawsuit
On December 7, 2011, however, the FDA warned hundreds of thousands of patients that it was investigating the safety of Pradaxa after receiving more injury or death reports from the drug than expected.

The Pradaxa Resource Center, a patient advocacy group, is alerting patients who have been prescribed the drug Pradaxa for their atrial fibrillation that the medication has been linked to risks of serious internal bleeding. Victims who have already filed a claim after being affected are awaiting a federal court decision on how the cases will be handled.

Anyone who has suffered internal bleeding or had a loved one affected by taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is a popular blood thinning drug prescribed to prevent strokes and blood clots in patients with atrial fibrillation. Although only on the market since October, 2010, Pradaxa has sold over $1 billion in the year ending February, 2012, according to a Wall Street Journal report on April 24, 2012.

On December 7, 2011, however, the FDA warned hundreds of thousands of patients that it was investigating the safety of Pradaxa after receiving more injury or death reports from the drug than expected.

The announcement came after Reuters reported in November that German drug maker Boehringer Ingelheim, who makes Pradaxa, admitted receiving more than 260 confirmed reports of death from internal bleeding among Pradaxa users since launching the drug worldwide in 2008.

Although all anticoagulants typically carry a risk of internal bleeding, most have a reversal agent available to doctors in emergency. A March 6, 2012 report by the Journal of Neurosurgery detailed a specific case and complaints by doctors that, once Pradaxa causes internal bleeding in a patient, there is very little they can do to stop it.

The Institute for Safe Medication Practices also reported on June 6, 2012 that Pradaxa led all other medications in 2011 for reports to the FDA of death or bleeding.

Due to the number of lawsuits expected over Pradaxa bleeding injury or death, lawyers filed a motion on May 30, 2012 requesting that all cases be moved to one central federal court. The case is known as MDL No. 2385 IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. In the motion, lawyers state they expect as many as 500 Pradaxa lawsuits will be filed.

The Pradaxa Resource Center believes moving all Pradaxa lawsuits into one federal court will expedite the litigation process and help victims share in valuable evidence. However, due to the specialized nature of these federal MDL cases, victims should make sure they choose a lawyer with experience in this type of litigation.

The Pradaxa Resource center works only with lawyers who are already handling Pradaxa lawsuits.

For more information on the research, warnings, side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Schroeder
Visit website